Food and Drug Administration - Disqualified/Restricted Lists for Clinical Investigators

The Food and Drug Administration (FDA) maintains a Disqualified/Restricted list for Clinical Investigators to ensure the integrity of clinical trials. This list identifies individuals who have been disqualified or restricted from conducting clinical investigations due to noncompliance with FDA regulations. Being on this list indicates serious concerns, such as issues with data integrity, patient safety, or ethical standards.

Mitigate risk with our comprehensive screening solutions for your AML and sanctions compliance.
234 Entities in Food and Drug Administration - Disqualified/Restricted Lists for Clinical Investigators
Entity NameEntity TypeEffective DateStatus

Gatenby Robert A

IndividualNov 15, 1988inactive

Musty Richard E

IndividualSep 20, 1990active

Straus Marc J

IndividualMay 18, 1982active

Swanson Todd V

IndividualApr 10, 2005active

Valdes Martin

IndividualOct 7, 2024inactive

Nukta Emad Dean

IndividualMar 26, 2008active

Teplick Steven K

IndividualMar 8, 1994active

Valdes Martin

IndividualSep 5, 2024active

Wallens William T

IndividualAug 22, 1983active

Weiss Jerome

IndividualDec 31, 1984active

FAQs

Why is compliance with Food and Drug Administration - Disqualified/Restricted List for Clinical Investigators necessary?

The Food and Drug Administration (FDA) Disqualified/Restricted List for Clinical Investigators is crucial for maintaining high standards in clinical trials. this list identifies researchers who may not meet the requirements set by the fda. it is vital for compliance professionals to understand why adherence to this list is necessary.

Which companies should comply with Food and Drug Administration - Disqualified/Restricted List for Clinical Investigators?

The Food and Drug Administration (FDA) disqualified/restricted list for clinical investigators impacts companies in the pharmaceutical, biotechnology, and medical device industries. These organizations must comply to ensure that clinical trials are conducted by qualified individuals. Compliance helps protect patient safety, maintains data integrity, and ensures that products meet regulatory standards before reaching the market.